Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation

Floris H. Groenendijk(Erasmus MC Cancer Institute), René Bernards(The Netherlands Cancer Institute)
International Journal of Cancer
August 1, 2014
Cited by 75


Related Papers